Repare Therapeutics Inc
NASDAQ:RPTX
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Repare Therapeutics Inc
Other Current Liabilities
Repare Therapeutics Inc
Other Current Liabilities Peer Comparison
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Other Current Liabilities
$10.4m
|
CAGR 3-Years
65%
|
CAGR 5-Years
120%
|
CAGR 10-Years
N/A
|
|
Zymeworks Inc
NYSE:ZYME
|
Other Current Liabilities
$8.7m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
Theratechnologies Inc
TSX:TH
|
Other Current Liabilities
$7.6m
|
CAGR 3-Years
29%
|
CAGR 5-Years
35%
|
CAGR 10-Years
20%
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Other Current Liabilities
$417k
|
CAGR 3-Years
-52%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Other Current Liabilities
$7.5m
|
CAGR 3-Years
46%
|
CAGR 5-Years
106%
|
CAGR 10-Years
9%
|
|
Spectral Medical Inc
TSX:EDT
|
Other Current Liabilities
CA$7.7m
|
CAGR 3-Years
126%
|
CAGR 5-Years
99%
|
CAGR 10-Years
9%
|
See Also
What is Repare Therapeutics Inc's Other Current Liabilities?
Other Current Liabilities
10.4m
USD
Based on the financial report for Dec 31, 2023, Repare Therapeutics Inc's Other Current Liabilities amounts to 10.4m USD.
What is Repare Therapeutics Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
120%
Over the last year, the Other Current Liabilities growth was -81%. The average annual Other Current Liabilities growth rates for Repare Therapeutics Inc have been 65% over the past three years , 120% over the past five years .